|
CARD ID
 |
1813 |
Type of strain |
Targeted mutant. |
Strain name |
B6;129-Mll1tm1.1Mlc |
Internal Code |
MlldC |
Submitter |
Yokoyama Akihiko |
Submitter affiliation or code |
Kyoto University Graduate School of Medicine Medical Innovation Center Laboratory for Malignancy Control Research DSK project |
Stock Type |
|
Material Transfer Conditions |
It is necessary to consent to the submitter. |
Production method |
From other organizations. |
Origin (In-house) |
Organization |
|
Organization code |
|
Developer |
|
Origin (From other organizations) |
Organization |
Stanford University Medical School |
Organization code |
Mlc |
Developer |
Michael L. Cleary |
Year introduced |
May
2009
|
Introduced Generation |
|
Remarks |
|
|
Gene symbol
 |
Mll1 |
Gene name |
myeloid/lymphoid or mixed-lineage leukemia 1 |
Allele symbol |
Mll1tm1.1Mlc |
Allele name |
myeloid/lymphoid or mixed-lineage leukemia 1; targeted mutation 1.1, Michael L Cleary |
MGI |
MGI:96995 |
Chromosome |
9 (24.84) |
Gene classification |
Targeted or trapped gene(knockout etc.) |
Method |
Electroporation |
OMIM |
|
|
|
PCR Primer |
dC&uc.fwd
|
gttctgaagcacacattccacacc
|
dC&uc.rev
|
catcaaagcgaagggcaatcagtg
|
|
reference information 1 |
|
Author
 |
Yokoyama, A., Ficara, F., Murphy, M. J., Meisel, C., Naresh, A., Kitabayashi, I. and Cleary, M. L. |
Title |
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways. |
Journal |
J Cell Sci |
Volume |
124 |
Page |
2208-2219 |
Year |
2011 |
PMID
|
|
|
Disease , Applicable field information
|
|
Disease name, Applicable field
|
Hematology, Endocrine Disorders, cancer, Cell biology, Molecular biology, Aging
|
|
|